Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close -
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Performance
Top News
More News
Merger Deal between Enzymotec and Frutarom Approved by 99.9% Majority of Enzymotec Shareholders
Completion of Transaction Expected Within 30 Days Read More
from GlobeNewswire News Releases
Enzymotec Shareholders Approve Proposed Acquisition by Frutarom
Enzymotec Ltd. (NASDAQ:ENZY) (“Enzymotec” or the “Company”), a developer, manufacturer and marketer of innovative bio-active lipid ingredients and nutritional products, today announced that at... Read More
from GlobeNewswire News Releases
More News
Read More
Enzymotec Ltd. Reports Third Quarter 2017 Unaudited Financial Results
from GlobeNewswire News Releases
Enzymotec Ltd. Calls 2017 Annual and Extraordinary General Meeting of Shareholders for Approval of Merger and Other Matters
from GlobeNewswire News Releases
Frutarom Will Acquire Full Ownership of the Specialty Nutrition Company Enzymotec at a Net Investment of Approx. USD 210M
from GlobeNewswire News Releases
Enzymotec Enters Definitive Agreement to be Acquired by Frutarom
from GlobeNewswire News Releases
Enzymotec Ltd. Expands VAYA Product Portfolio with Five Nutritional Supplements Acquired from Union Springs Healthcare
from GlobeNewswire News Releases
Enzymotec Ltd. Responds to Unsolicited Proposal from Frutarom Ltd.
from GlobeNewswire News Releases
BRIEF-Enzymotec Shareholders Approve Proposed Acquisition By Frutarom
category companyNews
from Reuters: Company News
BRIEF-Enzymotec Q3 non-GAAP earnings per share $0.07
category companyNews
from Reuters: Company News
Wall Street's M&A Chatter From October 27-30: Enzymotec-Frutarom, Akzo Nobel, Cleantech Solutions, Clariant-Huntsman
category AXTA , News , M&A , and 10 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.